Alx Oncology Holdings Inc

NASDAQ:ALXO   10:29:28 AM EDT
55.48
+0.52 (+0.95%)
Other Pre-Announcement

ALX Oncology Holdings Says Cash And Cash Equivalents As Of December 31, 2020 Were $434.2 Million

Published: 03/18/2021 21:36 GMT
Alx Oncology Holdings Inc (ALXO) - Alx Oncology Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Clinical Development and Operational Highlights and Upcoming Milestones.
Alx Oncology Holdings - Cash and Cash Equivalents As of December 31, 2020 Were $434.2 Million.
Alx Oncology Holdings - Believes Its Current Cash and Cash Equivalents Are Sufficient to Fund Planned Operations Through 2024.
Alx Oncology Holdings Inc - Qtrly Loss per Share $0.50.